দেশ: কানাডা
ভাষা: ইংরেজি
সূত্র: Health Canada
METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE)
PFIZER CANADA ULC
H02AB04
METHYLPREDNISOLONE
40MG
KIT
METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE) 40MG
INTRAMUSCULAR
10X1ML
Prescription
ADRENALS
Active ingredient group (AIG) number: 0106290002; AHFS:
CANCELLED POST MARKET
2015-09-15
PRODUCT MONOGRAPH Pr SOLU-MEDROL ® Methylprednisolone Sodium Succinate for Injection USP Sterile Powder 500 mg, 1 g Vials Pr SOLU-MEDROL ® ACT-O-VIALS ® Methylprednisolone Sodium Succinate for Injection USP Sterile Powder and Diluent 40 mg, 125 mg, 500 mg, 1 g Act-O-Vials with preservative 40 mg, 125 mg, 500 mg, 1 g Act-O-Vials without preservative Glucocorticoid Pfizer Canada Inc. 17,300 Trans-Canada Highway Kirkland, Quebec H9J 2M5 Date of Revision: 11 February 2015 Submission Control No: 178081 ® TM Pfizer Enterprises SARL Pfizer Canada Inc., Licensee ® TM Pharmacia & Upjohn Company LLC Pfizer Canada Inc., Licensee Pfizer Canada Inc. 2014 _ _ _SOLU-MEDROL (methylprednisolone sodium succinate) Product Monograph _ _Page 2 of 41_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION......................................................... 3 SUMMARY PRODUCT INFORMATION ........................................................................ 3 INDICATIONS AND CLINICAL USE .............................................................................. 3 CONTRAINDICATIONS ................................................................................................... 4 WARNINGS AND PRECAUTIONS.................................................................................. 5 ADVERSE REACTIONS ................................................................................................. 14 DRUG INTERACTIONS .................................................................................................. 17 DOSAGE AND ADMINISTRATION .............................................................................. 24 OVERDOSAGE ................................................................................................................ 26 ACTION AND CLINICAL PHARMACOLOGY ............................................................ 27 STORAGE AND STABILITY.......................................................................................... 29 DOSAGE FORMS, COMPOSITION AND PACKAGING .................. সম্পূর্ণ নথি পড়ুন